Trinlotan Co 50 μg/mL and 5 mg/mL eye drops, Solution
PDF Leaflet Revision Date: 30 June 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of intraocular pressure in open angle glaucoma and ocular hypertension.
Dosage (summary)
One drop in the affected eye(s) once daily.
Onset of Action / Duration
Onset: 1 hour, Duration: up to 24 hours
Special Populations
- Elderly
- Paediatric population
Pregnancy & Breastfeeding
Safety in pregnancy not established; contraindicated in breastfeeding.
Key Drug Interactions
- Caution with other beta-blockers
- Additive effects with calcium-channel blockers
Contraindications
- Hypersensitivity to active substances
- Bronchial asthma
- Cardiac failure
Common side effects
- Iris pigmentation changes
- Eye irritation
- Headache
Counselling Points
- Do not drive until vision is clear
- Remove contact lenses before use
- Monitor for eye irritation
Serious warnings
- Caution in patients with a history of herpetic keratitis
- Systemic effects may occur
Important Disclaimer
The Trinlotan Co 50 μg/mL and 5 mg/mL eye drops, Solution professional information leaflet below is the property of Trinity Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
